Results of treatment with ethambutol and capreomycin in chronic pulmonary tuberculosis.
D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D003638:Deafness / Q000139:chemically induced; D004977:Ethambutol / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced; D008297:Male; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification; D011379:Prognosis; D011859:Radiography; D013183:Sputum / Q000382:microbiology; D014397:Tuberculosis, Pulmonary / Q000000981:diagnostic imaging / Q000188:drug therapy*; D014717:Vertigo / Q000139:chemically induced
D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents; D004977:Ethambutol